Issue
Title
Authors
Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia
Shmalts A.A., Gorbachevsky S.V.
Socio-economic burden of pulmonary hypertension: relevance of assessment in Russia and the world
Zakiev V.D., Gvozdeva A.D., Martynyuk T.V.
COVID-19 and cardiovascular diseases
Chazova I.E., Mironova O.I.
The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat
Gratsianskaya S.E., Valieva Z.S., Martynyuk T.V.
Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry
Chazova I.E., Arkhipova O.A., Martynyuk T.V.
Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry
Chazova I.E., Valieva Z.S., Nakonechnikov S.N., Taran I.N., Martynyuk T.V.
New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension
Martynyuk T.V., Nakonechnikov S.N., Chazova I.Y.
A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults
Shmalts A.A., Gorbachevsky S.V.
Combination therapy is a new standard for treatment of pulmonary arterial hypertension
Avdeev S.N., Tsareva N.A., Gaisin I.R.
Evolution of pathogenetic therapy of pulmonary arterial hypertension
Chazova I.E., Yarovoy S.Y., Danilov N.M.
CURRENT RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
Avdeev S.N.
Perspectives of using pulmonary arterial stiffness indicators to evaluate the prognosis of patients with pulmonary arterial hypertension
Simakova M.A., Ryzhkov A.V., Kazymly A.V., Naimushin A.V., Lukinov V.L., Moiseeva O.M.
Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis
Volkov A.V., Kurmukov I.A., Iudkina N.N., Glukhova S.I., Nikolaeva E.V.
SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION, ASSOCIATED WITH SYSTEMIC SCLEROSIS
Volkov A.V., Martynyuk T.V., Yudkina N.N., Danilov N.M., Glukhova S.I., Guseva N.G., Chazova I.E., Nasonova V.A.
Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases
Nikolaeva E.V., Yudkina N.N., Kurmukov I.A., Novikova D.S., Markelova E.I., Volkov A.V.
The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension
Avdeev S.N.
Modern view on the place of riociguat in the treatment of pulmonary hypertension
Valieva Z.S., Taran I.N., Martynyuk T.V., Chazova I.Y.
Chronic obstructive pulmonary disease and comorbidities
Chuchalin A.G.
Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study
Volkov A.V., Nikolaeva E.V., Yudkina N.N., Kurmukov I.A., Nasonov E.L.
Efficacy and safetyof different p-blockers in patients with isolated systolic hypertension, associated with diabetes mellitus and obstructive pulmonary diseases
Kukes V.G., Ostroumova O.D., Mamaev V.I., Batutina A.M., Abakumov Y.E., Zykova A.A.
Role of vascular remodeling markers in the development of osteoporosis in idiopathic pulmonary arterial hypertension
Nevzorova V.A., Kochetkova E.A., Ugay L.G., Maistrovskaya Y.V., Khludeeva E.A.
Pharmacoeconomic aspects of macitentan in the therapy of pulmonary arterial hypertension
Moisseeva O.M., Rudakova A.V.
Comorbidity and polymorbidity of the patient with chronic obstructive pulmonary disease and cardiovascular diseases
Grigoryeva N.Y., Maiorova M.V., Korolyova M.E., Samolyuk M.O.
Pulse wave velocity and other indicators of arterial stiffness in hypertension comorbidity and chronic obstructive pulmonary disease
Aksenova T.A., Gorbunov V.V., Tsarenok S.Y.
Risk stratification methods and their significance in pulmonary arterial hypertension
Avdeev S.N., Tsareva N.A.
A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out?
Tsareva N.A., Avdeev S.N., Neklyudova G.V.
Bosentan use in pulmonary arterial hypertension: Russian and foreign experience
Valieva Z.S., Martynyuk T.V., Chazova I.E.
Chronic obstructive pulmonary disease and associated illnesses
Chuchalin A.G.
1 - 28 of 28 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies